J.P. Morgan (JPM) 2023 41st Annual Healthcare Conference in San Francisco
Did You Attend? J.P. Morgan (JPM) 2023 41st Annual Healthcare Conference in San Francisco Optimize your sell-side deal-making [...]
Pharma Industry News Weekly Recap: August 25, 2022
// Biotech and Pharma Therapeutics Backed by $40M, a biotech startup targets cancer with help from the immune [...]
Pharma Industry News Weekly Recap: August 18, 2022
// Biotech and Pharma Therapeutics CRISPR offers genetic clues to Alzheimer's in brain's cleaning crew August 16, 2022 / [...]
Pharma Industry News Weekly Recap: August 11, 2022
// Biotech and Pharma Therapeutics Lilly 'won't be discouraged' if others fail in Alzheimer's, neuroscience chief says August 4, [...]
Pharma Industry News Weekly Recap: August 4, 2022
// Biotech and Pharma Therapeutics Bayer-Ionis' anti-thrombotic med doesn't increase bleeding in phase 2, setting stage for a [...]
Pharma Industry News Weekly Recap: July 28, 2022
// Biotech and Pharma Therapeutics Is This Vertex Pharmaceuticals' Biggest News Yet? July 25, 2022 Pain / VX-548 [...]
Pharma Industry News Weekly Recap: September 2, 2021
// Biotech and Pharma Therapeutics [...]
Pharma Industry News Weekly Recap: August 5, 2021
// Biotech and Pharma Therapeutics The Kidney Medicine': Bayer Touts Kerendia's Blockbuster Potential As Its Pharma Group Swings [...]
Pharma Industry News Weekly Recap: July 29, 2021
// Biotech and Pharma Therapeutics New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar July 29, 2021 [...]
Pharma Industry News Weekly Recap: July 22, 2021
// Biotech and Pharma Therapeutics Roche CEO Schwan Puts 3-Time Alzheimer's Loser Gantenerumab Back In The Spotlight As FDA's [...]